Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
205.49
-2.29 (-1.10%)
At close: Sep 21, 2026, 4:00 PM EDT
205.97
+0.48 (0.23%)
After-hours: Sep 21, 2026, 5:18 PM EDT
Axsome Therapeutics Market Cap
Axsome Therapeutics has a market cap or net worth of $10.76 billion as of September 21, 2026. Its market cap has increased by 86.03% in one year.
Market Cap
10.76B
Enterprise Value
10.67B
1-Year Change
86.03%
Ranking
Category
Stock Price
$205.49
ChartMarket Cap Chart
Since November 19, 2015, Axsome Therapeutics's market cap has increased from $154.90M to $10.76B, an increase of 6,848.83%. That is a compound annual growth rate of 47.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 10.76B | 16.90% |
| Dec 31, 2025 | 9.21B | 124.55% |
| Dec 31, 2024 | 4.10B | 8.87% |
| Dec 29, 2023 | 3.77B | 12.44% |
| Dec 30, 2022 | 3.35B | 135.22% |
| Dec 31, 2021 | 1.42B | -53.19% |
| Dec 31, 2020 | 3.04B | -14.70% |
| Dec 31, 2019 | 3.57B | 4,141.14% |
| Dec 31, 2018 | 84.10M | -36.58% |
| Dec 29, 2017 | 132.60M | 2.55% |
| Dec 30, 2016 | 129.30M | -21.30% |
| Dec 31, 2015 | 164.30M | 6.07% |
| Nov 19, 2015 | 154.90M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Halozyme Therapeutics | 12.65B |
| BioMarin Pharmaceutical | 12.40B |
| Corcept Therapeutics | 12.30B |
| Madrigal Pharmaceuticals | 12.06B |
| Bio-Techne | 11.36B |
| Twist Bioscience | 10.40B |
| Krystal Biotech | 9.88B |
| Kymera Therapeutics | 9.80B |